Sie sind hier

Curriculum Vitae

Expand | Collapse

Theodoros Dimitroulas

Assistant Professor, School of Medicine

Personal Information

Bild des Benutzers dimitroul

dimitroul@auth.gr
http://www.rheumatologos.gr/
Scopus ID9943768300
Researcher ID0000-0002-0364-1642
PubMed IDDimitroulas+T
Γνωστικό Αντικείμενο:
ΡΕΥΜΑΤΟΛΟΓΙΑ
Επιστημονική Ειδίκευση:
- Υγεία
- Ιατρική
- Ιατρικές υπηρεσίες

Education

Προπτυχιακές Σπουδές

1999	Πτυχίο Ιατρικής Σχολής Τμήμα Ιατρκής, Σχολή Επιστημών Υγείας ΑΠΘ Greece

Μεταπτυχιακές Σπουδές

2005	ΜΔΕ Τμήμα Ιατρκής, Σχολή Επιστημών Υγείας ΑΠΘ

Διδακτορικό Δίπλωμα

2009	ΔΔ Τμήμα Ιατρκής, Σχολή Επιστημών Υγείας ΑΠΘ Greece

Μετεκπαίδευση

Ειδικευόμενος Παθολογίας 2003-2005 Νοσοκομείο ΑΧΕΠΑ

Ειδικευόμενος Ρευματολογίας 2005-2009 Νοσοκομείο ΑΧΕΠΑ

Clinical Research Fellow (8/2009 - 12/2010) and Consultant Rheumatologist (1/2011 - 02/2015) Dudley Group NHS and Royal Wolverhampton NHS FT, UK

Course Work

Courses of Winter semester of 2017–18 academic year

	TMĪMA IATRIKĪS
IA0366	Introduction to Pathological Physiology
ΙΑ0319	Internal Medicine
ΙΑ0321	Internal Medicine II

Courses of Spring semester of 2017–18 academic year

	TMĪMA IATRIKĪS
ΙΑ0319	Internal Medicine
ΙΑ0320	Internal Medicine I

Theses Supervised

Student Theses within AUTh

In progress

Pagkopoulou Eleni.

2017–2018

Soulaidopoulos Stergios. Η σχέση μεταξύ της μιρκο- και μακρο-αγγειοπάθειας σε ασθενείς με Συστηματική Σκληροδερμία. Προοπτική Κλινική Μελέτη

Administrative Work

Άλλο
#	Από	Έως	Θέση Περιγραφή
2	2012	2015	Υπεύθυνος του εκπαιδευτικού προγράμματος του ρευματολογικού τμήματος για το χρονικό διάστημα (Cannock Chase Hispital Royal Wolverhampton NHS Trust
1	2011	2012	Επικεφαλής του τμήματος κλινικών ερευνών (Research&Development) – Ρευματολογικός τομέας – του Dudley Group NHS

Research Projects

2010–2017

Νεοτερες εξελίξεις και δεδομένα στη Ρευματολογία

Publications

2017

Without Type

Bezzina OM, Gallagher P, Mitchell S, Bowman SJ, Griffiths B, Hindmarsh V, Hargreaves B, Price EJ, Pease CT, Emery P, Lanyon P, et al (2017). Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy. Arthritis Care Res (Hoboken). vol.69 no.11 p.1714-23.
Dimitroulas Theodoros, Hodson J, Panoulas VF, Sandoo A, Smith J, Kitas G (2017). Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene anddimethylarginines levels in rheumatoid arthritis. Amino Acids. vol.49 no.6.
Dimitroulas Theodoros, Hodson J, Sandoo A, Smith J, Kitas GD (2017). Endothelial injury inrheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation. Arthritis Research Therapy. vol.19.
Dimitroulas Theodoros, Lambe T, Klocke R, Kitas GD, Duarte RV (2017). Biologic drugs as analgesics for the management of osteoarthritis. Seminars in Arthritis and Rheumatism. vol. 46 no. 6 p. 687-691.
Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas Theodoros, Bratis K, Kitas GD, Sfikakis P, Tektonidou M, Karabela G, Stavropoulos E, Katsifis G, et al (2017). Cardiovascular magnetic resonance imaging pattern at the time ofdiagnosis of treatment naïve patients with connective tissue diseases. International Journal of Cardiology. vol. 236 p. 151-156.
Mavrogeni S, Koutsogeorgopoulou L, Dimitroulas Theodoros, Markousis-Mavrogenis G, Kolovou G (2017). Complementary role of cardiovascular imaging and laboratory indices in early detection of cardiovascular disease in systemic lupus erythematosus. Lupus.
Mavrogeni S.I, Sfikakis P.P, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Dimitroulas Theodoros, Kolovou G, Kitas G.D (2017). Cardiac Tissue Characterization and Imaging in Autoimmune Rheumatic Diseases. JACC Cardiovasc Imaging. vol.10 no.11 p.1387-96.
Ng WF, Miller A, Bowman SJ, Price EJ, Kitas GD, Pease C, Emery P, Lanyon P, Hunter J, UK Primary Sjögren’s Syndrome Registry, Dimitroulas Theodoros (2017). Physical activity but not sedentary activity Physical activity but not sedentary activityis reduced in primary Sjögren's syndrome. Rheumatology International. vol.37 no.4 p.623-631.
Pagkopoulou Eleni, Poutakidou Marina, Garyfallos Alexandros-Anastasios, KitasGeorge, Dimitroulas Theodoros (2017). Cardiovascular Risk in Systemic Sclerosis: Micro- and Macro-vascular Involvement. Indian Journal of Rheumatology. vol.12 p.S211-7.
Psarras A, Soulaidopoulos S, Garyfallos Alexandros-Anastasios, Kitas G, Dimitroulas Theodoros (2017). A critical view on cardiovascular risk in systemic sclerosis view on cardiovascular risk in systemic sclerosis. Rheumatology International. vol.37 no.1 p.85-95.

2016

Without Type

Boutou AK, Pitsiou Georgia, Siakka P, Dimitroulas Theodoros, Paspala A, Sourla E, Chavouzis N, Garyfallos Alexandros-Anastasios, Argyropoulou-Pataka Paraskevi, Stanopoulos I (2016). Phenotyping Exercise Limitation in Systemic Sclerosis: The Use of Cardiopulmonary Exercise Testing. Respiration. vol.91 no.2 p.115-23.
Dimitroulas Theodoros, Sandoo A, Hodson J, Smith JP, Kitas GD (2016). In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort. Scand J Clin Lab Invest. vol.76 no.4 p.331-7.
Dimitroulas Theodoros, Sandoo A, Hodson J, Smith J, Douglas KM, Kitas GD (2016). Associations between asymmetric dimethylarginine, homocysteine, and themethylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis. Scand J Rheumatol. vol.45 p.267–273.
Dimopoulou D, Trachana Maria, Pratsidou-Gertsi P, Sidiropoulos P, Kanakoudi-Tsakalidou Florentia, Dimitroulas Theodoros, Garyfallos Alexandros-Anastasios (2016). Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study. Rheumatology. vol.56 no.11 p.1928-38.
Dimopoulou D, Dimosiari A, Mandala Evdokia, Dimitroulas Theodoros, Garyfallos Alexandros-Anastasios (2016). AutoimmuneThrombotic Thrombocytopenic Purpura: Two Rare Cases Associated with Juvenile Idiopathic Arthritis and Multiple Sclerosis. Frontiers Medicine (Lausanne). vol.4 no.89.
Mavrogeni SI, Kitas GD, Dimitroulas Theodoros, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, et al (2016). Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use. Int J Cardiol. vol.217 p.135-48.
Oni C, Mitchell S, James K, Ng WF, Griffiths B, Hindmarsh V, Price E, Pease CT, Emery P, Lanyon P, Jones A, et al (2016). Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry. Rheumatology. vol.55 no.5 p.544-52.
Soulaidopoulos S, Triantafyllidou E, Garyfallos Alexandros-Anastasios, Kitas G.D, Dimitroulas Theodoros (2016). The role of nailfold capillaroscopy in the assessment of internal organinvolvement in systemic sclerosis: A critical review. Autoimmunity Reviews. vol.16 no.8 p.787-795.
Zegkos T, Kitas G, Dimitroulas Theodoros (2016). Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps. Ther Adv Musculoskelet Dis. vol.8 no.3 p.86-101.

2015

Without Type

Dimitroulas Theodoros, Sandoo A, Douglas K, Kitas GD (2015). Symmetric and asymmetric dimethylarginines as biochemical markers of endothelial and atherosclerosis in rheumatoid arthritis. Mediterranean Journal Rheumatology. vol.26 p.62-75.
Dimitroulas Theodoros, Hodson J, Sandoo A, Smith JP, Douglas KM, Kitas GD (2015). Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study. Mediators Inflamm. vol.2015 p.796562.
Dimitroulas Theodoros, Daoussis D, Garyfallos Alexandros-Anastasios, Sfikakis PP, Kitas GD (2015). Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis. Curr Med Chem. vol.22 no.16 p.1943-55.
Dimopoulou D, Dimitroulas Theodoros, Akriviadis Evangelos, Garyfallos Alexandros-Anastasios (2015). Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis. Rheumatology International. vol.11 no.5 p.1913-6.
Mavrogeni S, Sfikakis P, Dimitroulas Theodoros, Markousis-Mavrogenis G, Kolovou G, Kitas G (2015). Deciphering Cardiovascular Disease in Systemic Inflammatory Diseases Using Advanced Magnetic Resonance Imaging. Current Cardiovascular Imaging Reports. vol.8 no.4.
Mavrogeni S, Sfikakis PP, Dimitroulas Theodoros, Koutsogeorgopoulou L, Karabela G, Katsifis G, Stavropoulos E, Gialafos E, Spiliotis G, Kolovou G, Kitas GD (2015). Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance. Inflamm Allergy Drug Targets. vol.14 no.2 p.111-6.
Sandoo A, Dimitroulas Theodoros, Hodson J, Smith JP, Douglas KM, Kitas GD (2015). Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study. Rheumatology. vol.54 no.7 p.1145-5.
Zegkos Thomas, Kitas George, Dimitroulas Theodoros (2015). Symmetric dimethylarginine (SDMA) serum levels in rheumatoid arthritis: correlations with insulin resistance and disease activity scores. Amino Acids. vol.47 no.9 p.1995-2004.

2014

Without Type

Dimitroulas Theodoros, Sandoo A, Hodson J, Smith J, Panoulas VF, Kitas GD (2014). Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis. Atherosclerosis. vol.237 p.38-44.
Dimitroulas Theodoros, Duarte RV, Behura A, Kitas GD, Raphael JH (2014). Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment. Semin Arthritis Rheum. vol.44 no.2 p.145-54.
Dimitroulas Theodoros, Sandoo A, Smith JP, Kitas GD (2014). Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis. Int J Cardiol. vol.172 no.1 p.285-6.
Dimitroulas Theodoros, Giannakoulas Georgios, Karvounis Charalampos, Garyfallos Alexandros-Anastasios, Settas Loukas, Kitas GD (2014). Micro- and macrovascular treatment targets in scleroderma heart disease. Current Pharmaceutical Design. vol.20 no.4 p.536-44.
Duarte RV, Raphael JH, Dimitroulas Theodoros, Sparkes E, Southall JL, Ashford RL, Kitas GD (2014). Osteoarthritis pain has a significant neuropathic component: an exploratory in vivo patient model. Rheumatology International. vol.34 no.3 p.315-20.
Mavrogeni S, Dimitroulas Theodoros, Gabriel S, Sfikakis PP, Pohost GM, Kitas GD (2014). Why currently used diagnostic techniques for heart failure in rheumatoid arthritis are not enough: the challenge of cardiovascular magnetic resonance imaging. Rev Cardiovasc Med. 2014;15(4):320-31. vol.15 no.4 p. 320-31.
Mavrogeni S, Sfikakis PP, Dimitroulas Theodoros, Kolovou G, Kitas GD (2014). Cardiac and muscular involvement in idiopathic inflammatory myopathies: noninvasive diagnostic assessment and the role of cardiovascular and skeletal magnetic resonance imaging. Inflamm Allergy Drug Targets. vol.13 no.3 p.206-16.
Mavrogeni S, Sfikakis P, Dimitroulas Theodoros, Kolovou G, Kitas GD (2014). Edema and fibrosis imaging by cardiovascular magnetic resonance: how can the experience of Cardiology be best utilized in rheumatological practice?. Semin Arthritis Rheum. vol.44 no.1 p.76-85.
Mavrogeni S, Dimitroulas Theodoros, Bucciarelli-Ducci C, Ardoin S, Sfikakis PP, Kolovou G, Kitas GD (2014). Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic resonance. Inflamm Allergy Drug Targets. vol.13 no.2 p. 81-93.
Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJ, Nightingale P, Sandoo A, Dimitroulas Theodoros, Kitas GD, Koutedakis Y (2014). Individualised exercise improves endothelial function in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73:748-51. vol.73 no.4 p.748-51.

2013

Without Type

Dimitroulas Theodoros, Hirsch G, Kitas GD, Klocke R (2013). Clinical outcome of ultrasound-guided steroid injections for chronic shoulder pain. Int J Rheum Dis. vol.16 no.4 p.398-402.
Dimitroulas Theodoros, Douglas KM, Panoulas VF, Toms T, Smith JP, Treharne GJ, Nightingale P, Hodson J, Kitas GD (2013). Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors. Clin Rheumatol. 2013;32:1357-64. vol.32 no.9 p.1357-64.
Dimitroulas Theodoros, Nikas SN, Trontzas P, Kitas GD (2013). Biologic therapies and systemic bone loss in rheumatoid arthritis. Autoimmune Reviews. vol.12 no.10 p.958-66.
Dimitroulas Theodoros, Sandoo A, Veldhuijzen van Zanten JJ, Smith JP, Hodson J, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD (2013). Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance. Scand J Rheumatol. vol.42 no.3 p.176-81.
Dimitroulas Theodoros, Douglas KM, Smith J, Panoulas VF, Kitas GD (2013). Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritis. Rheumatology International.
Guillevin L, Hunsche E, Denton CP, Krieg T, Schwierin B, Rosenberg D, Matucci-Cerinic M, DUO Registry Group, Dimitroulas Theodoros (2013). Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. Clinical and Experimental Rheumatologuy. vol.31 p.71-80.
Mavrogeni S, Dimitroulas Theodoros, Sfikakis PP, Kitas GD (2013). Heart involvement in rheumatoid arthritis: multimodality imaging and the emerging role of cardiac magnetic resonance. Seminars in Arthritis and Rheumatism. vol.43 no.3 p.314-24.
Nordmark G, Wang C, Vasaitis L, Eriksson P, Theander E, Kvarnström M, Forsblad-d'Elia H, Jazebi H, Sjöwall C, Reksten TR, Brun JG, et al (2013). Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.: NF-jB Pathway Genes in Antibody-Positive pSS. Scand J Immunol. vol.78 no.5 p.447-54.

2012

Without Type

Denton CP, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Silkey M, Zultak M, Matucci-Cerinic M, DUO Registry investigators, Dimitroulas Theodoros (2012). Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry. Annals in Rheumatic Diseases.
Dimitroulas Theodoros, Sandoo A, Kitas GD (2012). Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases. International Journal of Molecular Science. vol.13 no.10 p.12315-35.
Dimitroulas Theodoros, Mavrogeni S, Kitas GD (2012). Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis. Nat Rev Rheumatol.
Dimitroulas Theodoros, Giannakoulas Georgios, Karvounis Charalampos, Garyfallos Alexandros-Anastasios, Settas Loukas, Kitas G (2012). B-type natriuretic peptide in rheumatic diseases: A cardiac biomarker or a sophisticated acute phase reactant?. Autoimmunity Reviews. vol.11 no.12 p.837–843.
Dimitroulas Theodoros, Giannakoulas Georgios, Karvounis Charalampos, Settas Loukas, Kitas GD (2012). Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets. Curr Pharm Des.
Mavrogeni S, Dimitroulas Theodoros, Chatziioannou SN, Kitas G (2012). The role of multimodality imaging in the evaluation of Takayasu arteritis. Seminars in Arthritis and Rheumatism. vol.42 no.2 p.401-12.
Mavrogeni S, Dimitroulas Theodoros, Kitas GD (2012). Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmun Rev. vol. 12 no. 2 p. 305–312.
Sandoo A, Dimitroulas Theodoros, Toms TE, Hodson J, Veldhuijzen van Zanten JJ, Smith JP, Kitas GD (2012). Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis. Clinical Biochemistry. vol. 45 no.16-17 p.1399–1403.
Sandoo A, Dimitroulas Theodoros, Veldhuijzen van Zanten JJ, Smith JP, Metsios GS, Nightingale P, Stavropoulos-Kalinoglou A, Kitas GD (2012). Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis. Clinical and Experimental Rheumatologuy.

2011

Without Type

Dimitroulas Theodoros, Giannakoulas Georgios, Karvounis Charalampos, Settas Loukas, Kitas G. D (2011). Biomarkers in systemic sclerosis-related pulmonary arterial hypertension. Current Vascular Pharmacology. vol.9 no.2 p.213-219.
Dimitroulas Theodoros, Giannakoulas Georgios, Dimitroula H, Sfetsios T, Parcharidou D, Karvounis Charalampos, Settas Loukas (2011). Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study. Rheumatology International. vol.31 no.2 p.263-267.

2010

Without Type

Dimitroula H, Damvopoulou E, Giannakoulas Georgios, Dalamanga E, Dimitroulas Theodoros, Sarafidis Panteleimon, Styliadis Ioannis, Chatzitolios Apostolos, Karvounis Charalampos, Parcharidis Georgios (2010). Effects of renin-angiotensin system inhibition on left atrial function of hypertensive patients: an echocardiographic tissue deformation imaging study. American Journal of Hypertension. vol.23 no.5 p.556-561.
Dimitroulas Theodoros, Giannakoulas Georgios, Karvounis Charalampos, Gatzoulis MA, Settas Loukas (2010). Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension. Seminars in Arthritis and Rheumatism. vol.30 no.4 p. 278–284.
Dimitroulas Theodoros, Sarafidis P, Roma V, Karagiannopoulou G, Kapoulas Stergios, Dimitroula H, Settas Loukas, Lasaridis A (2010). Scleroderma renal crisis accompanied by new-onset pulmonary arterial hypertension: an acute systemic endothelial injury? Case report and literature. Inflamm Allergy Drug Targets. vol.9 no.4 p.313-318.
Dimitroulas Theodoros, Giannakoulas Georgios, Papadopoulou-Legmpelou Kyriaki, Sfetsios T, Karvounis Charalampos, Dimitroula H, Parcharidou D, Koliakos Georgios, Garyfallos Alexandros-Anastasios, Styliadis Ioannis, Settas Loukas (2010). Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis. Clinical Rheumatology. vol.29 no.9 p.957-964.
Dimitroulas Theodoros, Giannakoulas Georgios, Papadopoulou-Legmpelou Kyriaki, Karvounis Charalampos, Dimitroula H, Koliakos Georgios, Karamitsos Theodoros, Parcharidou D, Settas Loukas (2010). Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction. The Journal of Rheumatology. vol.37 no.5 p.993-999.
Dimitroulas Theodoros, Giannakoulas Georgios, Karvounis Charalampos, Gatzoulis M. A, Settas Loukas (2010). Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension. Seminars in Arthritis and Rheumatism. vol.39 no.4 p.278-284.

2009

Without Type

Dimitroulas Theodoros, Settas Loukas (2009). Paget’s disease of the vulva a patient with systemic sclerosis and underlying adenocarcinoma: a case report. Eur J Gynaecol Oncol.
Dimitroulas Theodoros, Giannakoulas Georgios, Karvounis Charalampos, Dimitroula H, Settas Loukas (2009). N-terminal pro-brain natriuretic peptide in systemic sclerosis related pulmonary arterial hypertension under bosentan treatment. Rheumatol Int. vol.29 no.3 p.347-348.

2008

Without Type

Dimitroulas Theodoros, Giannakoulas Georgios, Sfetsios T, Karvounis Charalampos, Dimitroula H, Koliakos Georgios, Settas Loukas (2008). Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension. Rheumatology (Oxford). vol.47 no.11 p.1682-1685.
Dimitroulas Theodoros, Giannakoulas Georgios, Karvounis Charalampos, Settas Loukas (2008). Limitations of the findings regarding the relationship between N-terminal pro-brain natriuretic peptide and systemic sclerosis-related pulmonary arterial hypertension: comment on the article by Allanore et al. Arthritis Rheum. vol.58 no.7 p.2215-6; author reply 2216.
Dimitroulas Theodoros, Giannakoulas Georgios, Karvounis Charalampos, Koliakos Georgios, Sfetsios T, Dimitroula H, Settas Loukas (2008). N-terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension. Clin Rheumatol. vol.27 no.5 p.655-658.

2007

Without Type

Dimitroulas Theodoros, Giannakoulas Georgios, Karvounis Charalampos, Sfetsios T, Koliakos Georgios, Parcharidis Georgios, Settas Loukas (2007). Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension. International Journal of Cardiology. vol.121 no.1 p.135-137.
Δημητρούλας Θεόδωρος, Σφέτσιος Τ, Καρβούνης Χαράλαμπος, Κολιάκος Γεώργιος, Χαϊδάρη-Λαδίκου Δημητρούλα, Δαμβοπούλου Ε, Σέττας Λουκάς (2007). Το εγκεφαλικό νατριουρητικό πεπτίδιο (ΝΤ-proΒΝΡ) ως βιοχημικός δείκτης της ανταπόκρισης στη θεραπεία σε ασθενείς σε ασθενείς με Σκληροδερμία και Πνευμονική Υπέρταση. Ελληνική Ρευματολογία. vol.18 p.342-349.

2006

Without Type

Δημητρούλας Θεόδωρος, Σφέτσιος Τ, Πλιάκος Χριστόδουλος, Καρβούνης Χαράλαμπος, Κολιάκος Χ, Δημητρούλα Χ, Σέττας Λουκάς (2006). Μελέτη των επιπέδων του εγκεφαλικού νατριουρητικού πεπτιδίου (ΝΤ-proBNP) σε ασθενείς με σκληροδερμία και πνευμονική υπέρταση. vol.17 p.156-165.

2005

Without Type

Giannakoulas Georgios, Chatzitolios Apostolos, Karvounis Charalampos, Koliakos Georgios, Charitanti-Kouridou Afroditi, Dimitroulas Theodoros, Savvopoulos Christos, Tsirogianni Efrosini, Louridas Georgios (2005). N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology. vol 56 no. 6 p. 723-730.

2018

Without Type

Dimitroulas Theodoros, Sandoo A, Hodson J, Smith J, Douglas K, Kitas G (2018). Asymmetric Asymmetric dimethylarginine is associated with cumulative inflammation in rheumatoid arthritis. EULAR 2014. PARIS - FRANCE.

Aktualisiert: 2018-06-05